Calumet Specialty Valuation
| CLMT Stock | USD 21.38 0.45 2.06% |
At this time, the firm appears to be undervalued. Calumet Specialty shows a prevailing Real Value of $22.8 per share. The current price of the firm is $21.38. Our model approximates the value of Calumet Specialty from analyzing the firm fundamentals such as Profit Margin of (0.05) %, return on equity of -11.72, and Current Valuation of 3.86 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Calumet Specialty's valuation include:
Price Book 19.3228 | Enterprise Value 3.9 B | Enterprise Value Ebitda 689.5232 | Price Sales 0.4356 | Forward PE 11.3507 |
Undervalued
Today
Please note that Calumet Specialty's price fluctuation is not too volatile at this time. Calculation of the real value of Calumet Specialty is based on 3 months time horizon. Increasing Calumet Specialty's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Calumet Specialty's intrinsic value may or may not be the same as its current market price of 21.38, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 21.38 | Real 22.8 | Target 25.0 | Hype 21.43 |
The intrinsic value of Calumet Specialty's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Calumet Specialty's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Calumet Specialty Products helps investors to forecast how Calumet stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Calumet Specialty more accurately as focusing exclusively on Calumet Specialty's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Calumet Specialty's intrinsic value based on its ongoing forecasts of Calumet Specialty's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Calumet Specialty's closest peers.
Calumet Specialty Cash |
|
Calumet Valuation Trend
Calumet Specialty's real value is important for investors to make better decisions and a more accurate overall view of Calumet Specialty's financial worth over time. Using both Calumet Specialty's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Calumet Revenue by Product
Calumet Specialty Total Value Analysis
Calumet Specialty Products is currently expected to have valuation of 3.86 B with market capitalization of 1.84 B, debt of 2.19 B, and cash on hands of 50.5 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Calumet Specialty fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.86 B | 1.84 B | 2.19 B | 50.5 M |
Calumet Specialty Investor Information
About 21.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 2.71. Calumet Specialty recorded a loss per share of 2.82. The entity last dividend was issued on the 29th of January 2016. The firm had 1:1 split on the 11th of July 2024. Based on the key measurements obtained from Calumet Specialty's financial statements, Calumet Specialty Products is doing better financially today then in previous quarter. It has a moderate likelihood of reporting better financial numbers in January.Calumet Specialty Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Calumet Specialty has an asset utilization ratio of 151.96 percent. This implies that the Company is making $1.52 for each dollar of assets. An increasing asset utilization means that Calumet Specialty Products is more efficient with each dollar of assets it utilizes for everyday operations.Calumet Specialty Ownership Allocation
Calumet Specialty holds a total of 85.9 Million outstanding shares. Calumet Specialty Products retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Calumet Specialty Profitability Analysis
The company reported the previous year's revenue of 4.18 B. Net Income was 47.1 M with profit before overhead, payroll, taxes, and interest of 370.2 M.About Calumet Specialty Valuation
The stock valuation mechanism determines Calumet Specialty's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Calumet Specialty based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Calumet Specialty. We calculate exposure to Calumet Specialty's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Calumet Specialty's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 451.7 M | 315.1 M | |
| Pretax Profit Margin | 0.01 | 0.01 | |
| Operating Profit Margin | 0.06 | 0.07 | |
| Net Profit Margin | 0.01 | 0.01 | |
| Gross Profit Margin | 0.11 | 0.11 |
Calumet Specialty Growth Indicators
Investing in growth stocks can be very risky. If the company such as Calumet Specialty does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 80.1 M | |
| Quarterly Earnings Growth Y O Y | 5.617 | |
| Forward Price Earnings | 11.3507 |
Calumet Specialty Current Valuation Indicators
Calumet Specialty's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Calumet Specialty's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Calumet Specialty, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Calumet Specialty's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Calumet Specialty's worth.Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.